FundedIQ
Health Care

Endogenex: Funding, Investors & Team (Sep 2026)

Endogenex has created a new endoscopic procedure in 2017 that uses pulsed electric fields to help patients with type 2 diabetes better manage their blood sugar levels by promoting regeneration of the duodenal mucosa.

www.endogenex.com LinkedIn Plymouth, United States 11-50 employees
Health Care Medical Device Therapeutics
Total raised
$88.0M
Rounds
1
Latest
Series C
Jun 2024

Endogenex has raised $88.0M across 1 funding round on record, the most recent a Series C of $88.0M announced in Jun 2024.

That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.

Endogenex Company Profile and Key Stats

Total funding raised
$88.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series C
$88.0M in Jun 2024
Employees
11-50
reported band
Headquarters
Plymouth, United States

Latest funding round on record: Jun 2024.

Endogenex Funding Rounds

Date
Round
Amount
Series C
$88.0M

Endogenex Founders and Leadership Team

Name
Role
Contact
John Deedrick
Founder

No contact details are on record for this team yet.

Endogenex Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.8M
29,878
$7.5M
1,836
$60M

Endogenex's latest round of $88.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Endogenex in Health Care and Plymouth

Companies Similar to Endogenex

People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…

Undisclosed round $47.0M

Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…

Series E $125M

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…

Series A $14.0M

Happy Health is a mission-driven technology company committed to transforming mental health awareness through…

Undisclosed round $75.0M

Endogenex Funding FAQs

What does Endogenex do?

Endogenex has created a new endoscopic procedure in 2017 that uses pulsed electric fields to help patients with type 2 diabetes better manage their blood sugar levels by promoting regeneration of the duodenal mucosa.

How much funding has Endogenex raised?

Endogenex has raised $88.0M across 1 round on record. The most recent is a Series C of $88.0M announced in Jun 2024.

When did Endogenex last raise funding?

Endogenex's most recent funding round on record is a Series C of $88.0M, announced in Jun 2024.

Who founded Endogenex?

FundedIQ lists John Deedrick (Founder) at Endogenex.

Where is Endogenex headquartered?

Endogenex is based in Plymouth, Minnesota, United States.

How many employees does Endogenex have?

Endogenex is in the 11-50 employee band.

How does Endogenex's funding compare to other Health Care startups?

Endogenex's latest round of $88.0M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Endogenex Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Endogenex is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.